公开(公告)号：US20230250121A1

公开(公告)日：2023-08-10

申请号：US18015138

申请日：2021-07-07

Applicant: SUNSHINE LAKE PHARMA CO., LTD.

Inventor： Zheng GU ,  Tong QU ,  Wuyong WU ,  Weiming HUANG ,  Daoqian CHEN ,  Zongyuan ZHANG ,  Haoxiong QIN ,  Zheng LI ,  Weihui YUAN ,  Shijie NIU ,  Fei PENG ,  Tianyun WU

IPC: C07H1/00 ,  C07D295/108 ,  C07D295/26 ,  C07D317/22

CPC classification number: C07H1/00 ,  C07D295/108 ,  C07D295/26 ,  C07D317/22

Abstract: A method for preparing glucopyranosyl derivatives as sodium dependent glucose cotransporter (SGLT) inhibitors, an intermediate thereof, and a method for preparing the intermediate.

公开(公告)号：US20210054013A1

公开(公告)日：2021-02-25

申请号：US16965438

申请日：2019-01-29

Applicant: SUNSHINE LAKE PHARMA CO., LTD.

Inventor： Zheng GU ,  Wuyong WU ,  Panpan KANG ,  Tong QU ,  Zongyuan ZHANG ,  Weiming HUANG ,  Tianyun WU ,  Yingjun ZHANG

IPC: C07H9/04 ,  A61K45/06 ,  A61K31/7048 ,  A61P3/10

Abstract: A glucopyranosyl derivative is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The compound and a pharmaceutical composition is used thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.